India’s nutraceutical industry is expected to reach over US$ 22 billion in 2025
The program will offer a structured and immersive learning experience for over 20,000 healthcare professionals across more than 10 cities
Apollo AyurVAID’s product line features clinically proven formulations certified safe by NABL-accredited laboratories for heavy metals, aflatoxins, microbial content
Insights are drawn from over 30K+ people across 300+ cities including all metro and tier-1 cities
Surpassing 1,000 Company Owned Company Operated stores
Enhance strategies to drive sustainability, global Reach and digital transformation for a trillion-dollar future
Durvalumab in combination with carboplatin and paclitaxel is indicated for the first-line treatment of adults with primary advanced or recurrent endometrial cancer who are candidates for systemic therapy
She will lead efforts to deepen regional market presence, foster innovation, and support scientific advancement across South Asia
Subscribe To Our Newsletter & Stay Updated
